RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Humacyte, an innovator in biotechnology and regenerative medicine, announced today that Company founder, Laura Niklason, M.D., Ph.D., a world leader in tissue engineering and cellular therapies, will address the American Heart Association (AHA) Scientific Sessions. The conference, one of the leading cardiovascular meetings in the country, will be held from November 7-11 in Orlando, Fla.
Help employers find you! Check out all the jobs and post your resume.
